Some participants in the preliminary trials reported suffering adverse reactions from the vaccine, the company said.
Discover more from NEWS Daily
Subscribe to get the latest posts sent to your email.
Subscribe to get the latest posts sent to your email.
Subscribe now to keep reading and get access to the full archive.
